Dhampur Bio Organics Limited
Dhampur Bio Organics Limited (DBOL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Sugar
dhampur.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 666 Cr | 425 Cr | 595 Cr | 638 Cr | 634 Cr | 719 Cr | 703 Cr | 784 Cr | 825 Cr | 751 Cr | 774 Cr | 919 Cr |
| Operating expenses (approx.) | 646 Cr | 429 Cr | 513 Cr | 605 Cr | 643 Cr | 703 Cr | 607 Cr | 782 Cr | 833 Cr | 709 Cr | 679 Cr | 910 Cr |
| EBITDA | 19 Cr | -4 Cr | 81 Cr | 33 Cr | -10 Cr | 16 Cr | 96 Cr | 1 Cr | -8 Cr | 43 Cr | 95 Cr | 9 Cr |
| OPM % | 2.9% | -1.0% | 13.6% | 5.2% | -1.5% | 2.2% | 13.6% | 0.2% | -1.0% | 5.7% | 12.3% | 1.0% |
| Other income | 0.62 Cr | 16 Cr | 5 Cr | 0.78 Cr | 1 Cr | 0.43 Cr | 1 Cr | 2 Cr | 13 Cr | 9 Cr | 8 Cr | 1 Cr |
| Interest | 9 Cr | 6 Cr | 18 Cr | 21 Cr | 16 Cr | 10 Cr | 20 Cr | 22 Cr | 14 Cr | 11 Cr | 16 Cr | 16 Cr |
| Depreciation | 10 Cr | 14 Cr | 14 Cr | 12 Cr | 11 Cr | 15 Cr | 16 Cr | 14 Cr | 15 Cr | 15 Cr | 15 Cr | 13 Cr |
| Profit before tax | 0.48 Cr | -8 Cr | 54 Cr | 0.72 Cr | -35 Cr | -10 Cr | 61 Cr | -33 Cr | -23 Cr | 26 Cr | 72 Cr | 44 Cr |
| Tax % | 87.5% | 28.1% | 27.5% | 83.3% | 34.1% | 32.3% | 26.0% | 33.3% | 31.7% | 34.2% | 35.4% | -10.3% |
| Net profit | 0.06 Cr | -6 Cr | 39 Cr | 0.12 Cr | -23 Cr | -7 Cr | 45 Cr | -22 Cr | -16 Cr | 17 Cr | 46 Cr | 37 Cr |
| EPS (₹) | ₹0.01 | ₹-0.85 | ₹5.94 | ₹0.02 | ₹-3.52 | ₹-1.03 | ₹6.75 | ₹-3.31 | ₹-2.41 | ₹2.56 | ₹7.01 | ₹5.59 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 2,654 Cr | 2,394 Cr | 2,693 Cr | 3,133 Cr | Sign in for TTM |
| Operating expenses (approx.) | 2,450 Cr | 2,258 Cr | 2,558 Cr | 3,003 Cr | Sign in for TTM |
| EBITDA | 205 Cr | 136 Cr | 135 Cr | 131 Cr | Sign in for TTM |
| OPM % | 7.7% | 5.7% | 5.0% | 4.2% | Sign in for TTM |
| Other income | 11 Cr | 24 Cr | 4 Cr | 32 Cr | Sign in for TTM |
| Interest | 41 Cr | 45 Cr | 67 Cr | 63 Cr | Sign in for TTM |
| Depreciation | 41 Cr | 49 Cr | 54 Cr | 59 Cr | Sign in for TTM |
| Profit before tax | 135 Cr | 65 Cr | 16 Cr | 41 Cr | Sign in for TTM |
| Tax % | 17.6% | 29.0% | 6.5% | 38.4% | Sign in for TTM |
| Net profit | 111 Cr | 46 Cr | 15 Cr | 25 Cr | Sign in for TTM |
| EPS (₹) | ₹16.74 | ₹7.00 | ₹2.21 | ₹3.81 | Sign in for TTM |
| Dividend payout % | 0.0% | 49.7% | 113.8% | 33.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 66 Cr | 66 Cr | 66 Cr | 66 Cr |
| Reserves | 922 Cr | 945 Cr | 945 Cr | 960 Cr |
| Borrowings | 803 Cr | 1,047 Cr | 1,152 Cr | 1,054 Cr |
| Other liabilities | 285 Cr | 255 Cr | 234 Cr | 241 Cr |
| Total liabilities | 2,077 Cr | 2,313 Cr | 2,398 Cr | 2,322 Cr |
| Fixed assets (net) | 902 Cr | 1,027 Cr | 1,067 Cr | 1,125 Cr |
| CWIP | 36 Cr | 13 Cr | 79 Cr | 0.98 Cr |
| Investments | 0 Cr | 0 Cr | 0 Cr | 2 Cr |
| Loans & advances | 0 Cr | 0.08 Cr | 0.08 Cr | 0 Cr |
| Inventories | 819 Cr | 1,083 Cr | 1,094 Cr | 1,013 Cr |
| Trade receivables | 154 Cr | 88 Cr | 55 Cr | 64 Cr |
| Cash & bank | 104 Cr | 6 Cr | 9 Cr | 9 Cr |
| Other assets | 62 Cr | 97 Cr | 94 Cr | 108 Cr |
| Total assets | 2,077 Cr | 2,313 Cr | 2,398 Cr | 2,322 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operating activity | 355 Cr | -101 Cr | 130 Cr | 220 Cr |
| Cash from investing | -195 Cr | -166 Cr | -145 Cr | -42 Cr |
| Cash from financing | -78 Cr | 170 Cr | 19 Cr | -178 Cr |
| Net cash flow | 81 Cr | -98 Cr | 3 Cr | -0.17 Cr |
| Free cash flow (OCF − Capex) | 145 Cr | -272 Cr | -16 Cr | 176 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| ROCE % | 9.8% | 5.4% | 3.8% | 5.0% |
| ROE % | 11.2% | 4.6% | 1.7% | 2.5% |
| Debtor days | 21 | 13 | 7 | 7 |
| Inventory days | 188 | 246 | 292 | 250 |
| Days payable | 38 | 31 | 30 | 28 |
| Cash conversion cycle | 171 | 228 | 270 | 229 |
| Debt / equity | 0.81 | 1.03 | 1.14 | 1.03 |
| Current ratio | 1.31 | 1.19 | 1.14 | 1.16 |
| Net debt / EBITDA | 3.42 | 7.63 | 8.48 | 7.99 |
Compare with peers
Loading peers…